Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery

NCT07515391 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.

NCT NCT07515391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07515391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery
Lead sponsor
Dasman Diabetes Institute
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
October 22, 2019
Completion date
October 22, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery candidate, type2 diabetes